Key resources and tools to aid the implementation of disease characterisation studies during the COVID-19 outbreak, as well as the latest information regarding ongoing studies
Are you considering conducting a disease characterisation study? If so, then please let us know what you have planned and if you need any support. Are you looking for groups to collaborate with? Do you want to let others know that you would like to collaborate with another group?
We want to support any team wanting to undertake a high-quality COVID-19 study in different settings, and especially in LMICs. We can help coordinate discussions and support your plans. We can also set up a forum for developing ideas and asking questions. Please get in touch and get involved!
- Why do some Covid-19 patients have symptoms long after the virus goes away? The National Institutes of Health has allocated the first funds of a billion-dollar initiative to figure out why some people aren't recovering from Covid-19
- Genomic Surveillance for SARS-CoV-2 Variants by CDC
- New Variants of the viruts that causes COVID-19 by CDC (Feb 2021)
- Global Variants MAP by CDC
Navigate disease characterisation
What Support is Available?
Questions and enquiries regarding the WHO Early Investigation Protocols can be directed to EarlyInvestigations-2019-nCoV@who.int
In response to the emergence of COVID-19, the International Severe Acute Respiratory and Emerging Infection Consortium (ISARIC) has developed a portfolio of resources to accelerate outbreak research and response. The ISARIC Data Platform, an electronic data capture system and repository that standardises and secures global data on COVID-19, allows all those who contribute data to access high-level aggregate reports on global data and detailed reports on the data they enter. More information can be found here.
Fundação Oswaldo Cruz (Fiocruz) has created a resource area highlighting important sources of information about the pandemic, to facilitate the circulation of knowledge and help the entire scientific community to keep abreast of the latest news about the disease.